SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.2924C>TT975ILikely BenignUncertain 16-33443476-C-T63.72e-6-3.912Likely Benign0.164Likely BenignLikely Benign0.068Likely Benign-1.66Neutral0.411Benign0.239Benign4.11Benign0.66Tolerated4.3220-15.212.05
c.2971G>AG991RLikely BenignConflicting 36-33443523-G-A84.96e-6-3.934Likely Benign0.411AmbiguousLikely Benign0.102Likely Benign-1.20Neutral0.984Probably Damaging0.772Possibly Damaging4.11Benign0.01Affected4.322-3-2-4.199.14
c.13C>GR5GLikely BenignUncertain 1-3.639Likely Benign0.150Likely BenignLikely Benign0.169Likely Benign-0.16Neutral0.013Benign0.003Benign4.12Benign0.00Affected4.321-2-34.1-99.14
c.140G>AR47QLikely BenignLikely Benign 16-33423549-G-A42.48e-6-4.989Likely Benign0.347AmbiguousLikely Benign0.096Likely Benign-0.57Neutral0.829Possibly Damaging0.614Possibly Damaging4.12Benign0.00Affected4.321111.0-28.0610.1016/j.ajhg.2020.11.011
c.182A>CE61ALikely BenignUncertain 1-5.235Likely Benign0.453AmbiguousLikely Benign0.074Likely Benign-1.52Neutral0.458Possibly Damaging0.678Possibly Damaging4.12Benign0.00Affected0-15.3-58.04
c.2300T>CI767TLikely BenignUncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.291G>TE97DLikely BenignUncertain 36-33425899-G-T-3.239Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-0.49Neutral0.880Possibly Damaging0.636Possibly Damaging4.12Benign0.00Affected4.321320.0-14.03
c.3980C>TP1327LLikely BenignUncertain 16-33451854-C-T21.28e-6-5.264Likely Benign0.242Likely BenignLikely Benign0.142Likely Benign-1.24Neutral0.994Probably Damaging0.908Possibly Damaging4.12Benign0.10Tolerated3.775-3-35.416.04
c.3983G>AR1328QLikely BenignUncertain 36-33451857-G-A351.49e-4-2.921Likely Benign0.273Likely BenignLikely Benign0.043Likely Benign-1.02Neutral0.799Possibly Damaging0.098Benign4.12Benign0.03Affected3.775111.0-28.06
c.121C>TR41CLikely BenignConflicting 36-33423530-C-T74.34e-6-4.745Likely Benign0.207Likely BenignLikely Benign0.093Likely Benign-1.10Neutral0.976Probably Damaging0.919Probably Damaging4.13Benign0.00Affected4.321-4-37.0-53.05
c.2324G>CR775PLikely BenignBenign 1-5.072Likely Benign0.452AmbiguousLikely Benign0.168Likely Benign-0.79Neutral0.971Probably Damaging0.944Probably Damaging4.13Benign0.07Tolerated3.646-202.9-59.07
c.2573G>AS858NLikely BenignUncertain 16-33443125-G-A21.24e-6-4.311Likely Benign0.121Likely BenignLikely Benign0.107Likely Benign-0.67Neutral0.448Benign0.846Possibly Damaging4.13Benign0.02Affected3.77511-2.727.03
c.280C>TP94SLikely BenignBenign 16-33425888-C-T53.10e-6-3.151Likely Benign0.084Likely BenignLikely Benign0.093Likely Benign-2.36Neutral0.092Benign0.008Benign4.13Benign0.00Affected4.3211-10.8-10.04
c.2924C>AT975NLikely BenignUncertain 16-33443476-C-A16.20e-7-4.671Likely Benign0.089Likely BenignLikely Benign0.100Likely Benign-0.58Neutral0.586Possibly Damaging0.302Benign4.13Benign0.07Tolerated4.32200-2.813.00
c.29G>CR10PLikely BenignUncertain 26-33420293-G-C21.30e-6-3.772Likely Benign0.162Likely BenignLikely Benign0.220Likely Benign-0.05Neutral0.233Benign0.026Benign4.13Benign0.00Affected4.3210-22.9-59.07
c.611C>GS204C
(3D Viewer)
Likely BenignPHUncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.218G>AR73KLikely BenignUncertain 16-33425826-G-A21.24e-6-4.033Likely Benign0.151Likely BenignLikely Benign0.077Likely Benign-0.46Neutral0.053Benign0.007Benign4.14Benign0.00Affected4.321230.6-28.01
c.2873A>CH958PLikely BenignBenign 16-33443425-A-C21.24e-6-8.369Likely Pathogenic0.068Likely BenignLikely Benign0.204Likely Benign-0.36Neutral0.925Possibly Damaging0.316Benign4.14Benign0.10Tolerated3.7750-21.6-40.02
c.416G>AS139NLikely BenignUncertain 16-33432713-G-A32.22e-6-4.584Likely Benign0.688Likely PathogenicLikely Benign0.109Likely Benign-0.75Neutral0.149Benign0.047Benign4.14Benign0.24Tolerated3.61511-2.727.03
c.136C>TP46SLikely BenignUncertain 1-3.338Likely Benign0.302Likely BenignLikely Benign0.066Likely Benign-0.60Neutral0.909Possibly Damaging0.901Possibly Damaging4.15Benign0.00Affected1-10.8-10.04
c.2116G>AE706K
(3D Viewer)
GAPUncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous0.080Likely Benign1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.471001-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2888A>GH963RLikely BenignUncertain 16-33443440-A-G84.96e-6-8.952Likely Pathogenic0.169Likely BenignLikely Benign0.081Likely Benign-1.28Neutral0.001Benign0.003Benign4.15Benign0.24Tolerated3.77520-1.319.05
c.2900G>TR967LLikely BenignUncertain 16-33443452-G-T16.20e-7-3.496Likely Benign0.164Likely BenignLikely Benign0.123Likely Benign-0.99Neutral0.959Probably Damaging0.586Possibly Damaging4.15Benign0.75Tolerated4.322-2-38.3-43.03
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.3964G>CA1322PLikely BenignBenign 16-33451838-G-C-1.153Likely Benign0.063Likely BenignLikely Benign0.090Likely Benign0.03Neutral0.000Benign0.000Benign4.15Benign0.23Tolerated3.7751-1-3.426.04
c.901G>AA301T
(3D Viewer)
Likely BenignC2Uncertain 56-33437806-G-A21.24e-6-3.448Likely Benign0.070Likely BenignLikely Benign0.150Likely Benign0.36Likely Benign0.2-0.33Likely Benign0.02Likely Benign0.03Likely Benign-0.25Neutral0.997Probably Damaging0.989Probably Damaging4.15Benign0.22Tolerated4.321410-2.530.03219.8-42.8-0.10.0-0.50.2UncertainThe methyl group of Ala301, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), points outward from the β hairpin loop, and its backbone atoms do not participate in the loop formation in the WT simulations. In the variant simulations, the hydroxyl group of the Thr301 side chain also mostly points outward; however, the guanidinium group of Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.103G>AV35ILikely BenignUncertain 16-33423512-G-A53.10e-6-3.764Likely Benign0.081Likely BenignLikely Benign0.017Likely Benign-0.32Neutral0.672Possibly Damaging0.369Benign4.16Benign0.00Affected4.321340.314.03
c.106C>TH36YLikely BenignUncertain 16-33423515-C-T21.24e-6-3.461Likely Benign0.139Likely BenignLikely Benign0.023Likely Benign-1.03Neutral0.219Benign0.066Benign4.16Benign0.00Affected4.321021.926.03
c.1222A>GT408AC2Uncertain 1-8.304Likely Pathogenic0.114Likely BenignLikely Benign0.118Likely Benign0.37Likely Benign0.6-0.06Likely Benign0.16Likely Benign0.72Ambiguous-3.07Deleterious0.540Possibly Damaging0.131Benign4.16Benign0.14Tolerated102.5-30.03
c.2567A>GN856SLikely BenignUncertain 16-33443119-A-G21.24e-6-2.104Likely Benign0.064Likely BenignLikely Benign0.040Likely Benign-1.54Neutral0.901Possibly Damaging0.535Possibly Damaging4.16Benign0.30Tolerated3.883112.7-27.03
c.2924C>GT975SLikely BenignUncertain 1-2.743Likely Benign0.068Likely BenignLikely Benign0.109Likely Benign-0.57Neutral0.059Benign0.061Benign4.16Benign0.20Tolerated11-0.1-14.03
c.3238G>TA1080SLikely BenignUncertain 16-33443790-G-T16.26e-7-3.277Likely Benign0.108Likely BenignLikely Benign0.103Likely Benign0.01Neutral0.702Possibly Damaging0.346Benign4.16Benign0.08Tolerated3.77511-2.616.00
c.43G>AA15TLikely BenignUncertain 16-33420307-G-A42.60e-6-3.720Likely Benign0.125Likely BenignLikely Benign0.086Likely Benign-0.08Neutral0.602Possibly Damaging0.017Benign4.16Benign0.00Affected4.32110-2.530.03
c.526A>CS176RLikely BenignUncertain 1-6.492Likely Benign0.987Likely PathogenicLikely Pathogenic0.247Likely Benign0.94Neutral0.718Possibly Damaging0.168Benign4.16Benign0.87Tolerated0-1-3.769.11
c.2324G>AR775QLikely BenignConflicting 36-33442482-G-A111.41e-5-4.476Likely Benign0.229Likely BenignLikely Benign0.085Likely Benign-0.63Neutral0.969Probably Damaging0.863Possibly Damaging4.17Benign0.16Tolerated3.646111.0-28.0610.1016/j.ajhg.2020.11.011
c.2989G>AA997TLikely BenignUncertain 1-4.102Likely Benign0.071Likely BenignLikely Benign0.085Likely Benign-0.62Neutral0.224Benign0.120Benign4.17Benign0.00Affected4.32410-2.530.03
c.29G>AR10QLikely BenignUncertain 26-33420293-G-A201.30e-5-4.438Likely Benign0.185Likely BenignLikely Benign0.084Likely Benign0.03Neutral0.121Benign0.004Benign4.17Benign0.00Affected4.321111.0-28.06
c.1312G>AA438T
(3D Viewer)
Likely BenignGAPConflicting 36-33438217-G-A169.91e-6-5.339Likely Benign0.085Likely BenignLikely Benign0.021Likely Benign0.21Likely Benign0.0-0.07Likely Benign0.07Likely Benign0.36Likely Benign-0.81Neutral0.300Benign0.011Benign4.18Benign0.14Tolerated3.382610-2.530.03214.2-42.7-0.30.1-0.40.1XPotentially BenignThe methyl group of Ala438, located in a four-residue loop connecting two α helices (res. Asn440-Thr458 and Pro413-Glu436), packs against hydrophobic residues from a nearby α helix or loop residues (e.g., Leu703, Val699). In the variant simulations, the methyl group of Thr438 is able to establish similar hydrophobic packing. Moreover, the hydroxyl group also H-bonds with nearby residues, such as the carbonyl group of the neighboring loop residue Pro437. Accordingly, the residue swap does not generate an apparent negative effect on the protein structure based on the simulations.
c.2557G>CG853RLikely BenignUncertain 1-4.749Likely Benign0.366AmbiguousLikely Benign0.091Likely Benign-1.27Neutral0.846Possibly Damaging0.624Possibly Damaging4.18Benign0.00Affected-3-2-4.199.14
c.502C>TH168YLikely BenignBenign 1-8.914Likely Pathogenic0.264Likely BenignLikely Benign0.065Likely Benign-1.53Neutral0.192Benign0.062Benign4.18Benign0.01Affected4.323021.926.03
c.172A>GM58VLikely BenignUncertain 1-2.211Likely Benign0.688Likely PathogenicLikely Benign0.160Likely Benign-0.71Neutral0.006Benign0.091Benign4.19Benign0.00Affected4.321122.3-32.06
c.194A>GH65RLikely BenignUncertain 16-33425802-A-G16.20e-7-1.980Likely Benign0.967Likely PathogenicLikely Pathogenic0.073Likely Benign-1.60Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.32120-1.319.05
c.382C>AP128TLikely BenignUncertain 16-33432247-C-A16.20e-7-4.217Likely Benign0.267Likely BenignLikely Benign0.075Likely Benign-0.96Neutral0.952Possibly Damaging0.500Possibly Damaging4.19Benign0.35Tolerated3.744-100.93.99
c.3941C>TP1314LLikely BenignLikely Benign 16-33451815-C-T21.24e-6-4.040Likely Benign0.118Likely BenignLikely Benign0.049Likely Benign-0.20Neutral0.421Benign0.066Benign4.19Benign0.05Affected3.775-3-35.416.04
c.44C>TA15VLikely BenignUncertain 16-33420308-C-T16.49e-7-3.560Likely Benign0.161Likely BenignLikely Benign0.105Likely Benign0.20Neutral0.602Possibly Damaging0.015Benign4.19Benign0.00Affected4.321002.428.05
c.2928T>GF976LLikely BenignUncertain 1-2.432Likely Benign0.825Likely PathogenicAmbiguous0.212Likely Benign-0.87Neutral0.264Benign0.102Benign4.20Benign0.53Tolerated4.322201.0-34.02
c.2299A>GI767VLikely BenignUncertain 1-2.791Likely Benign0.064Likely BenignLikely Benign0.096Likely Benign0.10Neutral0.072Benign0.029Benign4.21Benign1.00Tolerated3.64643-0.3-14.03
c.2393C>TP798LLikely BenignSH3-binding motifUncertain 26-33442945-C-T63.72e-6-5.640Likely Benign0.074Likely BenignLikely Benign0.042Likely Benign-0.86Neutral0.981Probably Damaging0.631Possibly Damaging4.21Benign0.00Affected4.321-3-35.416.04
c.2900G>AR967QLikely BenignBenign/Likely benign 26-33443452-G-A311.92e-5-3.057Likely Benign0.080Likely BenignLikely Benign0.104Likely Benign-0.01Neutral0.994Probably Damaging0.626Possibly Damaging4.21Benign0.36Tolerated4.322111.0-28.06
c.304T>GL102VLikely BenignUncertain 16-33432169-T-G16.20e-7-4.316Likely Benign0.068Likely BenignLikely Benign0.102Likely Benign0.32Neutral0.880Possibly Damaging0.899Possibly Damaging4.21Benign0.00Affected4.321210.4-14.03
c.1260T>GF420L
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.432Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.146Likely Benign1.76Ambiguous0.01.41Ambiguous1.59Ambiguous1.04Destabilizing-5.39Deleterious0.009Benign0.005Benign4.22Benign0.39Tolerated3.3729201.0-34.02231.113.20.00.0-0.10.0XPotentially BenignIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). In the variant simulations, the iso-butyl side chain of Leu420 also packs into the hydrophobic inter-helix niche, but due to its smaller size, the resulting steric interactions are not as favorable as with phenylalanine. In short, the residue swap does not cause severe effects on the protein structure based on the variant simulations.
c.2932C>TP978SLikely BenignUncertain 1-3.913Likely Benign0.151Likely BenignLikely Benign0.085Likely Benign-1.07Neutral0.481Possibly Damaging0.220Benign4.22Benign0.48Tolerated1-10.8-10.04
c.2935T>CF979LLikely BenignUncertain 1-2.341Likely Benign0.870Likely PathogenicAmbiguous0.228Likely Benign-1.00Neutral0.625Possibly Damaging0.430Benign4.22Benign0.73Tolerated4.322201.0-34.02
c.323A>GK108RLikely BenignUncertain 16-33432188-A-G63.72e-6-2.892Likely Benign0.148Likely BenignLikely Benign0.184Likely Benign0.37Neutral0.993Probably Damaging0.956Probably Damaging4.22Benign1.00Tolerated3.61532-0.628.01
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.2381C>TP794LLikely BenignSH3-binding motifBenign/Likely benign 26-33442933-C-T734.52e-5-3.808Likely Benign0.079Likely BenignLikely Benign0.075Likely Benign-0.80Neutral0.761Possibly Damaging0.321Benign4.24Benign0.03Affected4.073-3-35.416.04
c.2578G>AV860ILikely BenignBenign 16-33443130-G-A211.30e-5-4.516Likely Benign0.095Likely BenignLikely Benign0.039Likely Benign-0.42Neutral0.009Benign0.006Benign4.24Benign0.00Affected3.775430.314.03
c.2983C>TP995SLikely BenignUncertain 1-4.457Likely Benign0.071Likely BenignLikely Benign0.042Likely Benign-1.03Neutral0.011Benign0.015Benign4.24Benign0.00Affected4.3211-10.8-10.04
c.303C>AH101QLikely BenignUncertain 16-33432168-C-A16.20e-7-2.827Likely Benign0.124Likely BenignLikely Benign0.147Likely Benign-0.37Neutral0.824Possibly Damaging0.880Possibly Damaging4.24Benign0.00Affected4.32130-0.3-9.01
c.3962C>AP1321QLikely BenignBenign 16-33451836-C-A16.58e-7-5.594Likely Benign0.079Likely BenignLikely Benign0.055Likely Benign-0.74Neutral0.659Possibly Damaging0.034Benign4.24Benign0.09Tolerated3.7750-1-1.931.01
c.286G>AG96SLikely BenignUncertain 16-33425894-G-A53.10e-6-3.049Likely Benign0.065Likely BenignLikely Benign0.071Likely Benign-0.76Neutral0.364Benign0.008Benign4.25Benign0.00Affected4.32110-0.430.03
c.37A>GI13VLikely BenignUncertain 1-2.497Likely Benign0.105Likely BenignLikely Benign0.110Likely Benign0.01Neutral0.000Benign0.000Benign4.25Benign0.00Affected43-0.3-14.03
c.3958C>TP1320SLikely BenignUncertain 16-33451832-C-T21.28e-6-4.928Likely Benign0.073Likely BenignLikely Benign0.097Likely Benign-0.69Neutral0.980Probably Damaging0.968Probably Damaging4.25Benign0.00Affected3.7751-10.8-10.04
c.3979C>TP1327SLikely BenignUncertain 16-33451853-C-T-4.744Likely Benign0.131Likely BenignLikely Benign0.092Likely Benign0.28Neutral0.980Probably Damaging0.857Possibly Damaging4.25Benign0.71Tolerated3.7751-10.8-10.04
c.3G>AM1ILikely BenignConflicting 3-5.397Likely Benign0.227Likely Benign-0.17Neutral0.001Benign0.000Benign4.25Benign0.00Affected4.321212.6-18.03
c.2987C>GP996RLikely BenignBenign 1-4.457Likely Benign0.141Likely BenignLikely Benign0.040Likely Benign-1.04Neutral0.144Benign0.085Benign4.26Benign0.01Affected4.324-20-2.959.07
c.3961C>TP1321SLikely BenignUncertain 26-33451835-C-T106.46e-6-4.897Likely Benign0.077Likely BenignLikely Benign0.049Likely Benign0.68Neutral0.028Benign0.004Benign4.27Benign0.71Tolerated3.7751-10.8-10.0410.1016/j.ajhg.2020.11.011
c.597C>AN199K
(3D Viewer)
PHUncertain 1-8.198Likely Pathogenic0.686Likely PathogenicLikely Benign0.024Likely Benign-0.19Likely Benign0.10.03Likely Benign-0.08Likely Benign0.33Likely Benign-1.48Neutral0.276Benign0.083Benign4.27Benign0.13Tolerated3.47910-0.414.07207.821.5-0.11.50.10.0XUncertainAsn199, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by a positively charged lysine. On the protein surface, both the carboxamide group of Asn199 and the amino group of Lys199 side chains can form hydrogen bonds with the backbone carbonyl groups of residues (e.g., Ala249) at the end of an α helix (res. Ala236-Lys251). However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.2914C>TP972SLikely BenignUncertain 16-33443466-C-T42.48e-6-4.008Likely Benign0.058Likely BenignLikely Benign0.074Likely Benign-0.38Neutral0.001Benign0.002Benign4.28Benign0.05Affected4.322-110.8-10.04
c.48G>AM16ILikely BenignUncertain 16-33420312-G-A16.49e-7-2.198Likely Benign0.722Likely PathogenicLikely Benign0.057Likely Benign-0.15Neutral0.000Benign0.000Benign4.28Benign0.00Affected4.321212.6-18.03
c.127G>AG43SLikely BenignUncertain 26-33423536-G-A16.20e-7-3.301Likely Benign0.078Likely BenignLikely Benign0.057Likely Benign-0.30Neutral0.162Benign0.096Benign4.29Benign0.00Affected4.32110-0.430.03
c.2914C>GP972ALikely BenignUncertain 16-33443466-C-G16.20e-7-0.167Likely Benign0.045Likely BenignLikely Benign0.046Likely Benign-0.89Neutral0.016Benign0.011Benign4.29Benign0.07Tolerated4.322-113.4-26.04
c.2548G>AG850RLikely BenignUncertain 1-5.082Likely Benign0.398AmbiguousLikely Benign0.194Likely Benign-0.07Neutral0.010Benign0.010Benign4.30Benign0.01Affected3.775-3-2-4.199.14
c.603T>AD201E
(3D Viewer)
Likely BenignPHBenign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.603T>GD201E
(3D Viewer)
Likely BenignPHConflicting 26-33435245-T-G201.24e-5-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3970C>TP1324SLikely BenignLikely Benign 16-33451844-C-T53.26e-6-5.451Likely Benign0.068Likely BenignLikely Benign0.049Likely Benign0.35Neutral0.225Benign0.092Benign4.33Benign0.00Affected4.3211-10.8-10.04
c.59C>GP20RLikely BenignUncertain 1-3.548Likely Benign0.434AmbiguousLikely Benign0.146Likely Benign-0.15Neutral0.972Probably Damaging0.804Possibly Damaging4.33Benign0.00Affected4.3210-2-2.959.07
c.86T>CM29TLikely BenignUncertain 1-2.167Likely Benign0.122Likely BenignLikely Benign0.199Likely Benign-0.37Neutral0.018Benign0.184Benign4.33Benign0.00Affected4.321-1-1-2.6-30.09
c.3368G>AG1123DUncertain 16-33443920-G-A21.33e-6-10.321Likely Pathogenic0.405AmbiguousLikely Benign0.360Likely Benign-0.78Neutral0.500Possibly Damaging0.157Benign4.34Benign0.19Tolerated3.7751-1-3.158.04
c.3943T>CW1315RLikely BenignUncertain 10.205Likely Benign0.660Likely PathogenicLikely Benign0.114Likely Benign1.31Neutral0.000Benign0.001Benign4.37Benign0.91Tolerated3.7752-3-3.6-30.03
c.4021G>TA1341SLikely BenignUncertain 16-33451895-G-T-2.867Likely Benign0.078Likely BenignLikely Benign0.099Likely Benign0.80Neutral0.000Benign0.001Benign4.40Benign1.00Tolerated3.77511-2.616.00
c.82T>CS28PLikely BenignUncertain 1-3.309Likely Benign0.051Likely BenignLikely Benign0.047Likely Benign1.37Neutral0.000Benign0.000Benign4.53Benign0.00Affected4.3211-1-0.810.04
c.2837G>AG946ELikely BenignBenign 36-33443389-G-A138.05e-6-8.793Likely Pathogenic0.257Likely BenignLikely Benign0.341Likely Benign-0.51Neutral0.818Possibly Damaging0.355Benign4.58Benign0.00Affected4.3240-2-3.172.06
c.3374G>CG1125ALikely BenignUncertain 16-33443926-G-C16.68e-7-6.569Likely Benign0.083Likely BenignLikely Benign0.232Likely Benign-0.60Neutral0.999Probably Damaging0.995Probably Damaging4.60Benign0.11Tolerated3.775102.214.03
c.1153T>CS385P
(3D Viewer)
Likely BenignC2Uncertain 16-33438058-T-C-5.431Likely Benign0.123Likely BenignLikely Benign0.385Likely Benign0.91Ambiguous0.6-0.90Ambiguous0.01Likely Benign0.19Likely Benign-0.26Neutral0.676Possibly Damaging0.693Possibly Damaging4.63Benign0.04Affected4.3231-1-0.810.04210.318.51.80.90.30.0UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Pro385 is potentially tolerated in the Ω loop. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1154C>GS385W
(3D Viewer)
C2Benign 16-33438059-C-G-9.353Likely Pathogenic0.362AmbiguousLikely Benign0.373Likely Benign0.53Ambiguous0.20.69Ambiguous0.61Ambiguous0.00Likely Benign-0.84Neutral0.986Probably Damaging0.968Probably Damaging4.63Benign0.00Affected4.323-2-3-0.199.14260.4-71.20.51.30.70.4UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.10.1016/j.ajhg.2020.11.011
c.1154C>TS385L
(3D Viewer)
Likely BenignC2Uncertain 26-33438059-C-T94.60e-5-6.018Likely Benign0.167Likely BenignLikely Benign0.304Likely Benign0.16Likely Benign0.10.08Likely Benign0.12Likely Benign-0.26Likely Benign-0.68Neutral0.829Possibly Damaging0.706Possibly Damaging4.63Benign0.01Affected4.323-3-24.626.08244.6-50.10.00.6-0.10.1UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1306G>AE436K
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.869Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.829Likely Pathogenic0.56Ambiguous0.12.86Destabilizing1.71Ambiguous0.82Ambiguous-3.77Deleterious0.994Probably Damaging0.951Probably Damaging4.71Benign0.02Affected3.372901-0.4-0.94186.839.80.00.0-0.20.0XXXPotentially PathogenicThe carboxylate group of Glu436, located on the α helix (res. Met414-Glu436), forms a salt bridge with the amino group of the Lys444 side chain on an opposing α helix (res. Val441-Ser457). The backbone carbonyl of Glu436 also H-bonds with the Lys444 side chain, which helps keep the ends of the two α helices tightly connected. In contrast, in the variant simulations, the salt bridge formation with Lys444 is not possible. Instead, the repelled Lys436 side chain rotates outward, causing a change in the α helix backbone H-bonding: the amide group of Lys444 H-bonds with the carbonyl of Ala433 instead of the carbonyl of Cys432.
c.3376G>TG1126CLikely BenignUncertain 16-33443928-G-T117.35e-6-9.389Likely Pathogenic0.113Likely BenignLikely Benign0.449Likely Benign-1.40Neutral0.005Benign0.005Benign4.74Benign0.02Affected3.775-3-32.946.09
c.3377G>TG1126VLikely BenignUncertain 16-33443929-G-T-6.536Likely Benign0.089Likely BenignLikely Benign0.357Likely Benign-1.20Neutral0.009Benign0.008Benign4.76Benign0.03Affected3.775-1-34.642.08
c.3370G>AG1124RConflicting 36-33443922-G-A241.60e-5-8.918Likely Pathogenic0.534AmbiguousLikely Benign0.243Likely Benign-0.58Neutral0.002Benign0.002Benign4.81Benign0.01Affected3.775-3-2-4.199.14
c.3380G>TG1127VLikely BenignUncertain 16-33443932-G-T16.69e-7-6.097Likely Benign0.094Likely BenignLikely Benign0.230Likely Benign-1.01Neutral0.004Benign0.005Benign4.81Benign0.17Tolerated4.324-1-34.642.08
c.3377G>AG1126DUncertain 1-8.888Likely Pathogenic0.432AmbiguousLikely Benign0.376Likely Benign-0.65Neutral0.906Possibly Damaging0.473Possibly Damaging4.82Benign0.02Affected3.7751-1-3.158.04
c.3380G>CG1127ALikely BenignConflicting 46-33443932-G-C42.68e-6-5.949Likely Benign0.080Likely BenignLikely Benign0.164Likely Benign-0.43Neutral0.001Benign0.002Benign4.83Benign1.00Tolerated4.324102.214.03
c.3379G>AG1127RLikely BenignUncertain 16-33443931-G-A21.34e-6-5.949Likely Benign0.629Likely PathogenicLikely Benign0.341Likely Benign-0.87Neutral0.001Benign0.001Benign4.86Benign0.12Tolerated4.324-2-3-4.199.14
c.3379G>CG1127RLikely BenignConflicting 26-33443931-G-C161.07e-5-5.949Likely Benign0.629Likely PathogenicLikely Benign0.341Likely Benign-0.87Neutral0.001Benign0.001Benign4.86Benign0.12Tolerated4.324-2-3-4.199.14
c.3364G>AG1122SLikely BenignBenign/Likely benign 26-33443916-G-A271.79e-5-4.880Likely Benign0.072Likely BenignLikely Benign0.189Likely Benign-0.08Neutral0.022Benign0.006Benign4.89Benign0.92Tolerated3.77510-0.430.03
c.2840G>CG947ALikely BenignLikely Benign 16-33443392-G-C281.73e-5-6.511Likely Benign0.080Likely BenignLikely Benign0.156Likely Benign-0.41Neutral0.224Benign0.131Benign4.97Benign0.10Tolerated4.324102.214.03
c.2835T>AH945QLikely BenignConflicting 26-33443387-T-A31.86e-6-5.248Likely Benign0.091Likely BenignLikely Benign0.343Likely Benign-0.36Neutral0.995Probably Damaging0.939Probably Damaging5.03Benign0.06Tolerated4.32430-0.3-9.01
c.3354C>AS1118RLikely BenignUncertain 1-2.670Likely Benign0.553AmbiguousLikely Benign0.166Likely Benign-0.74Neutral0.034Benign0.023Benign5.17Benign0.05Affected4.322-10-3.769.11
c.3170G>AS1057NLikely BenignUncertain 1-6.386Likely Benign0.117Likely BenignLikely Benign0.218Likely Benign-0.41Neutral0.451Benign0.129Benign5.25Benign0.28Tolerated11-2.727.03
c.3410A>CH1137PLikely BenignBenign 16-33444445-A-C127.44e-6-2.098Likely Benign0.054Likely BenignLikely Benign0.419Likely Benign-1.93Neutral0.925Possibly Damaging0.703Possibly Damaging5.29Benign0.00Affected4.324-201.6-40.02
c.3567G>CE1189DLikely BenignCoiled-coilLikely Benign 16-33444602-G-C31.86e-6-3.582Likely Benign0.461AmbiguousLikely Benign0.359Likely Benign-1.42Neutral0.992Probably Damaging0.989Probably Damaging5.30Benign0.25Tolerated3.824320.0-14.03
c.1199T>AV400E
(3D Viewer)
Likely PathogenicC2Uncertain 1-13.686Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.810Likely Pathogenic3.70Destabilizing0.22.46Destabilizing3.08Destabilizing2.29Destabilizing-4.88Deleterious0.920Possibly Damaging0.335Benign5.31Benign0.00Affected3.3827-2-2-7.729.98249.1-38.8-0.10.11.00.0XXXPotentially PathogenicThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). In the variant simulations, the negatively charged carboxylate group of the Glu400 side chain is not suitable for occupying the hydrophobic niche. Consequently, the side chain escapes the center of the C2 domain and interacts with the backbone amide groups of Leu402 in the same β strand and/or Ile269 and Glu270 in a neighboring β strand (res. Arg259-Arg272). This residue swap disrupts the hydrophobic packing and generally has extensive negative effects on the C2 domain structure. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.3508A>GS1170GLikely BenignCoiled-coilUncertain 1-4.288Likely Benign0.221Likely BenignLikely Benign0.349Likely Benign-0.81Neutral0.241Benign0.229Benign5.31Benign0.54Tolerated4.324100.4-30.03
c.3511_3512delinsTGA1171CLikely BenignCoiled-coilUncertain 1-5.363Likely Benign0.496AmbiguousLikely Benign-1.16Neutral0.978Probably Damaging0.825Possibly Damaging5.32Benign0.02Affected4.324-200.732.06
c.1198G>CV400L
(3D Viewer)
Likely BenignC2Benign 16-33438103-G-C221.36e-5-1.000Likely Benign0.137Likely BenignLikely Benign0.325Likely Benign-0.71Ambiguous0.20.39Likely Benign-0.16Likely Benign-0.29Likely Benign-0.60Neutral0.001Benign0.001Benign5.33Benign0.64Tolerated3.382721-0.414.03251.0-30.10.00.00.70.1XPotentially BenignThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). Val400 is swapped for another hydrophobic residue, leucine, whose branched hydrocarbon side chain is of a comparable size and thus packs favorably within the C2 domain. In short, the residue swap has no apparent negative effect on the structure based on the variant simulations.10.1016/j.ajhg.2020.11.011
c.3172G>AG1058SLikely BenignConflicting 36-33443724-G-A1147.08e-5-5.178Likely Benign0.081Likely BenignLikely Benign0.108Likely Benign0.26Neutral0.001Benign0.001Benign5.38Benign0.04Affected3.77510-0.430.03
c.3394T>CS1132PLikely BenignConflicting 36-33443946-T-C16.74e-7-1.423Likely Benign0.144Likely BenignLikely Benign0.301Likely Benign0.38Neutral0.003Benign0.006Benign5.40Benign0.28Tolerated4.3241-1-0.810.04
c.3395C>AS1132YLikely BenignLikely Benign 1-5.894Likely Benign0.392AmbiguousLikely Benign0.401Likely Benign-1.76Neutral0.500Possibly Damaging0.208Benign5.40Benign0.09Tolerated4.324-3-2-0.576.10
c.3633G>AM1211ILikely BenignCoiled-coilUncertain 16-33446625-G-A31.86e-6-1.537Likely Benign0.764Likely PathogenicLikely Benign0.298Likely Benign-0.42Neutral0.969Probably Damaging0.968Probably Damaging5.40Benign1.00Tolerated3.775122.6-18.03
c.1121C>AS374Y
(3D Viewer)
C2Uncertain 1-7.774In-Between0.344AmbiguousLikely Benign0.310Likely Benign0.71Ambiguous1.20.66Ambiguous0.69Ambiguous-0.02Likely Benign-1.18Neutral0.875Possibly Damaging0.271Benign5.41Benign0.01Affected4.3213-3-2-0.576.10237.3-76.90.50.40.50.3UncertainSer374 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus, large and relatively hydrophobic residues like tyrosine are rarely tolerated. Additionally, the hydroxyl group of Tyr374 frequently forms various hydrogen bonds with other loop residues in the variant simulations. Although no negative structural effects are observed in the variant simulations, Tyr374 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1195G>AA399T
(3D Viewer)
Likely BenignC2Benign 1-5.236Likely Benign0.114Likely BenignLikely Benign0.272Likely Benign1.24Ambiguous0.10.91Ambiguous1.08Ambiguous0.49Likely Benign-0.40Neutral0.131Benign0.039Benign5.41Benign0.69Tolerated3.382610-2.530.03211.4-41.40.00.00.60.4XPotentially PathogenicThe methyl group of Ala399, located in an anti-parallel β sheet strand (res. Ala399-Ile411), is swapped for a hydroxyl-containing threonine. In the variant simulations, the hydroxyl group of Thr399 can form H-bonds with the backbone atoms of the residues in the membrane-facing loops (e.g., Gly382) in the C2 domain. Consequently, the ability of the Thr399 side chain to form H-bonds with the membrane-facing loops could adversely affect the dynamics and stability of the SynGAP-membrane association. However, since the effects on the dynamics of the membrane-facing loops can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.3413C>AS1138YUncertain 16-33444448-C-A31.86e-6-6.610Likely Benign0.449AmbiguousLikely Benign0.391Likely Benign-2.51Deleterious0.997Probably Damaging0.996Probably Damaging5.41Benign0.05Affected4.324-2-3-0.576.10
c.3405G>CK1135NLikely BenignUncertain 1-5.715Likely Benign0.960Likely PathogenicLikely Pathogenic0.166Likely Benign-0.97Neutral0.411Benign0.321Benign5.43Benign0.07Tolerated4.322100.4-14.07
c.3631A>GM1211VLikely BenignCoiled-coilBenign 16-33446623-A-G31.86e-6-2.101Likely Benign0.258Likely BenignLikely Benign0.412Likely Benign-0.29Neutral0.932Possibly Damaging0.949Probably Damaging5.43Benign0.72Tolerated3.775122.3-32.06
c.3386T>CL1129PLikely BenignUncertain 2-2.991Likely Benign0.154Likely BenignLikely Benign0.432Likely Benign0.27Neutral0.971Probably Damaging0.773Possibly Damaging5.44Benign0.00Affected4.324-3-3-5.4-16.04
c.3487C>GH1163DUncertain 1-2.107Likely Benign0.949Likely PathogenicAmbiguous0.476Likely Benign-2.60Deleterious0.991Probably Damaging0.991Probably Damaging5.44Benign0.31Tolerated3.8831-1-0.3-22.05
c.3529G>AE1177KLikely BenignCoiled-coilUncertain 1-3.413Likely Benign0.944Likely PathogenicAmbiguous0.560Likely Pathogenic-1.75Neutral0.905Possibly Damaging0.637Possibly Damaging5.44Benign0.11Tolerated4.32201-0.4-0.94
c.3511G>AA1171TLikely BenignCoiled-coilUncertain 1-3.658Likely Benign0.149Likely BenignLikely Benign0.201Likely Benign-0.48Neutral0.245Benign0.138Benign5.45Benign0.07Tolerated4.32410-2.530.03
c.1131G>AM377I
(3D Viewer)
Likely BenignC2Uncertain 16-33438036-G-A16.23e-7-2.895Likely Benign0.212Likely BenignLikely Benign0.227Likely Benign0.76Ambiguous0.30.54Ambiguous0.65Ambiguous0.24Likely Benign-0.41Neutral0.000Benign0.001Benign5.46Benign0.26Tolerated4.3212122.6-18.03
c.2852A>GH951RLikely BenignLikely Pathogenic 1-4.964Likely Benign0.125Likely BenignLikely Benign0.185Likely Benign-1.08Neutral0.048Benign0.029Benign5.46Benign0.24Tolerated3.77520-1.319.05
c.3404A>CK1135TLikely BenignConflicting 26-33443956-A-C16.75e-7-4.778Likely Benign0.779Likely PathogenicLikely Benign0.210Likely Benign-0.90Neutral0.411Benign0.321Benign5.46Benign0.10Tolerated4.3220-13.2-27.07
c.1202G>AR401Q
(3D Viewer)
Likely PathogenicC2Uncertain 16-33438107-G-A-11.213Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.780Likely Pathogenic0.96Ambiguous0.11.50Ambiguous1.23Ambiguous1.20Destabilizing-3.69Deleterious0.999Probably Damaging0.978Probably Damaging5.47Benign0.04Affected3.3827111.0-28.06
c.3397A>GI1133VLikely BenignBenign 16-33443949-A-G221.48e-5-3.362Likely Benign0.067Likely BenignLikely Benign0.180Likely Benign0.06Neutral0.007Benign0.007Benign5.47Benign0.58Tolerated4.32343-0.3-14.0310.1016/j.ajhg.2020.11.011
c.3502A>GI1168VLikely BenignUncertain 1-3.263Likely Benign0.524AmbiguousLikely Benign0.363Likely Benign-0.14Neutral0.876Possibly Damaging0.643Possibly Damaging5.47Benign0.84Tolerated3.88343-0.3-14.03
c.703T>CS235P
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.857Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.870Likely Pathogenic4.02Destabilizing0.16.91Destabilizing5.47Destabilizing1.23Destabilizing-4.24Deleterious0.917Possibly Damaging0.446Benign5.47Benign0.01Affected3.40141-1-0.810.04201.517.00.10.0-0.60.0XPotentially PathogenicIn the WT, the hydroxyl group of Ser235, located in a β-α loop between an anti-parallel β sheet strand (res. Gly227-Phe231) and an α helix (residues Ala236-Val250), forms hydrogen bonds with the GAP domain loop residue Glu680 and with the backbone amide groups of Ala237 and Glu238 from the α helix. In the variant simulations, the pyrrolidine ring of Pro235 cannot stabilize the α helix end or maintain tertiary bonding interactions between the PH and GAP domains via hydrogen bonding as effectively as serine.
c.3121C>TP1041SLikely BenignConflicting 26-33443673-C-T16.20e-7-4.246Likely Benign0.121Likely BenignLikely Benign0.344Likely Benign-2.72Deleterious0.664Possibly Damaging0.283Benign5.48Benign0.11Tolerated3.7751-10.8-10.04
c.3125A>GQ1042RLikely BenignUncertain 26-33443677-A-G21.24e-6-2.928Likely Benign0.413AmbiguousLikely Benign0.300Likely Benign-1.39Neutral0.586Possibly Damaging0.120Benign5.48Benign0.12Tolerated3.77511-1.028.06
c.3607C>GH1203DLikely BenignCoiled-coilUncertain 1-6.729Likely Benign0.525AmbiguousLikely Benign0.403Likely Benign-1.89Neutral0.473Possibly Damaging0.265Benign5.51Benign0.24Tolerated3.7751-1-0.3-22.05
c.3520G>AE1174KLikely BenignCoiled-coilUncertain 16-33444555-G-A21.24e-6-4.345Likely Benign0.898Likely PathogenicAmbiguous0.442Likely Benign-1.59Neutral0.962Probably Damaging0.367Benign5.52Benign0.03Affected4.32201-0.4-0.94
c.3434A>GN1145SLikely BenignUncertain 16-33444469-A-G21.24e-6-0.989Likely Benign0.126Likely BenignLikely Benign0.308Likely Benign-1.15Neutral0.997Probably Damaging0.989Probably Damaging5.55Benign0.89Tolerated4.324112.7-27.03
c.3607C>TH1203YLikely BenignCoiled-coilUncertain 16-33446599-C-T21.24e-6-6.834Likely Benign0.149Likely BenignLikely Benign0.233Likely Benign-1.52Neutral0.006Benign0.011Benign5.55Benign0.10Tolerated3.775201.926.03
c.670A>GT224A
(3D Viewer)
PHUncertain 36-33435521-A-G21.24e-6-7.379In-Between0.651Likely PathogenicLikely Benign0.464Likely Benign0.33Likely Benign0.11.05Ambiguous0.69Ambiguous0.91Ambiguous-2.96Deleterious0.243Benign0.079Benign5.57Benign0.57Tolerated3.4113102.5-30.03169.041.4-0.51.1-0.40.0XXUncertainThe introduced residue Ala224 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the hydroxyl group of the Thr224 side chain in the WT model, the methyl side chain of Ala224 cannot form hydrogen bonds with nearby residues Ser204, Ser226, and Gly227. Without these hydrogen-bonding interactions at the β sheet surface, the secondary structure element becomes unstable and unfolds during the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3632T>AM1211KLikely PathogenicCoiled-coilLikely Benign 1-9.013Likely Pathogenic0.662Likely PathogenicLikely Benign0.595Likely Pathogenic-2.95Deleterious0.987Probably Damaging0.979Probably Damaging5.59Benign0.01Affected3.7750-1-5.8-3.02
c.742C>TR248W
(3D Viewer)
Likely PathogenicPHUncertain 1-11.647Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.699Likely Pathogenic1.17Ambiguous0.3-0.20Likely Benign0.49Likely Benign0.89Ambiguous-6.98Deleterious1.000Probably Damaging0.948Probably Damaging5.62Benign0.00Affected3.41142-33.630.03266.442.30.00.00.30.1XPotentially PathogenicThe guanidinium group of Arg248, located on an α helix (res. Ala236-Val250), forms two very stable salt bridges with Asp255 (from a short α helical section, res. Lys254-Asn256) and Glu244 (from a nearby loop) in the WT simulations. In the variant simulations, the indole group of Trp248 cannot form any salt bridges, which could negatively affect the tertiary structure assembly of the PH domain. Instead, in the variant simulations, the indole ring of Trp248 stacks against Pro252, which makes a turn after the α helix.
c.743G>CR248P
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-10.751Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.848Likely Pathogenic3.09Destabilizing0.68.87Destabilizing5.98Destabilizing1.21Destabilizing-5.97Deleterious0.998Probably Damaging0.878Possibly Damaging5.64Benign0.00Affected3.41140-22.9-59.07223.8126.60.00.0-0.20.1XXPotentially PathogenicThe guanidinium group of Arg248, located on an α helix (residues Ala236-Val250), forms two very stable salt bridges with Asp255 (from a short α helical section, res. Lys254-Asn256) and Glu244 (from a nearby loop) in the WT simulations. In the variant simulations, the pyrrolidine side chain of Pro248 cannot form any salt bridges, which could negatively affect the tertiary structure assembly of the PH domain. Additionally, Pro248 lacks a free amide group needed for hydrogen bonding with the backbone carbonyl group of Asn245, disrupting the continuity of the α helix.
c.745G>AA249T
(3D Viewer)
Likely BenignPHUncertain 1-3.564Likely Benign0.805Likely PathogenicAmbiguous0.487Likely Benign1.50Ambiguous0.61.39Ambiguous1.45Ambiguous0.30Likely Benign-0.96Neutral0.990Probably Damaging0.815Possibly Damaging5.65Benign0.40Tolerated3.391510-2.530.03214.5-43.30.00.00.50.2XPotentially BenignThe methyl group of Ala249, located on the surface of an α helix (res. Ala236-Val250) facing an anti-parallel β sheet strand (res. Ile205-Val209), packs against nearby hydrophobic residues such as Leu200, Leu246, and Val250. In the variant simulations, the hydroxyl group of Thr249, which is not suitable for hydrophobic packing, forms a stable hydrogen bond with the backbone carbonyl of Asn245 in the same helix. Although this interaction could theoretically weaken the structural integrity of the α helix, this destabilizing effect is not observed in the variant simulations.
c.1193C>TP398L
(3D Viewer)
C2Uncertain 16-33438098-C-T84.96e-6-7.518In-Between0.547AmbiguousLikely Benign0.599Likely Pathogenic1.48Ambiguous0.2-0.54Ambiguous0.47Likely Benign0.62Ambiguous-7.10Deleterious0.961Probably Damaging0.256Benign5.72Benign0.01Affected3.4016-3-35.416.04245.8-68.6-0.10.0-0.30.2XPotentially PathogenicPro398 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. Although the residue swap does not influence the nearby secondary structure elements, proline is often found at the ends of β sheets due to its disfavored status during folding.Additionally, the Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone. Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Leu398 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.680G>AG227E
(3D Viewer)
Likely PathogenicPHConflicting 26-33435531-G-A31.86e-6-9.186Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.792Likely Pathogenic2.56Destabilizing0.45.36Destabilizing3.96Destabilizing0.94Ambiguous-6.49Deleterious0.906Possibly Damaging0.360Benign5.72Benign0.01Affected3.43120-2-3.172.06237.7-112.10.10.30.00.3XXUncertainThe introduced residue Glu227 is located in a β hairpin loop connecting two anti-parallel β sheet strands (res. Cys219-Thr224 and Thr228-Ala232). In the variant simulations, the carboxylate group of Glu227 frequently forms a salt bridge with the amino group of the neighboring residue Lys229. Despite this interaction, the integrity of the secondary structure element is not compromised. However, the β hairpins are potential nucleation sites during the initial stages of protein folding. Additionally, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.667A>GT223A
(3D Viewer)
PHUncertain 16-33435518-A-G31.86e-6-7.076In-Between0.316Likely BenignLikely Benign0.574Likely Pathogenic0.30Likely Benign0.10.77Ambiguous0.54Ambiguous0.74Ambiguous-3.36Deleterious0.231Benign0.058Benign5.74Benign0.09Tolerated3.4113102.5-30.03186.444.00.00.00.00.0XXUncertainThe introduced residue Ala223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the hydroxyl group of the Thr223 side chain in the WT protein, the methyl side chain of Ala223 cannot form hydrogen bonds with nearby residues Thr228 and Lys207. Without these hydrogen-bonding interactions at the β sheet surface, the secondary structure element becomes unstable and partially unfolds in the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.700C>TR234W
(3D Viewer)
Likely PathogenicPHUncertain 16-33435551-C-T31.86e-6-12.625Likely Pathogenic0.947Likely PathogenicAmbiguous0.805Likely Pathogenic0.96Ambiguous0.30.69Ambiguous0.83Ambiguous0.13Likely Benign-5.52Deleterious0.997Probably Damaging0.803Possibly Damaging5.76Benign0.01Affected3.40142-33.630.03262.839.6-0.10.0-0.20.2XPotentially PathogenicThe guanidinium group of Arg234, located in a β-α loop between an anti-parallel β sheet strand (residues Gly227-Phe231) and an α helix (res. Ala236-Val250), forms a salt bridge with the carboxylate group of Glu238 in the α helix. Occasionally, it also bonds with the GAP domain residues Ser678 and Glu680. Thus, the positively charged Arg234 could contribute to the tertiary structure assembly between the PH and GAP domains. In contrast, the indole side chain of Trp234 in the variant is located on the protein surface in the variant simulations and is unable to form any interactions.
c.775C>TR259W
(3D Viewer)
Likely PathogenicC2Uncertain 1-12.186Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.691Likely Pathogenic1.95Ambiguous0.80.51Ambiguous1.23Ambiguous0.51Ambiguous-7.35Deleterious1.000Probably Damaging0.993Probably Damaging5.76Benign0.00Affected3.39152-33.630.03254.040.00.20.20.20.4XXXPotentially PathogenicThe guanidinium group of Arg259, located at the beginning of an anti-parallel β sheet strand (res. Arg259-Arg272), forms salt bridges with the carboxylate groups of Asp684 at the end of an α helix (res. Ile683-Gln702, GAP domain) and Asp261 on the same β strand. The Arg259 side chain also frequently forms hydrogen bonds with the backbone carbonyl groups of Ser257, Asn256, and Asp255. In the variant simulations, the indole ring of the Trp259 side chain cannot form salt bridges or maintain hydrogen bonding with the carboxylate group of Asp684 or other nearby residues. Notably, the amino group of the Lys254 side chain maintains a salt bridge with Asp684 and Glu244 throughout the variant simulations, while it forms a cation-π bond with the indole ring of Trp259 in the variant. This salt bridge is not maintained in the WT simulations. Additionally, the partially or loosely α helical conformation of a lysine-containing loop (res. Lys251-Ser257), which extends to a nearby α helix (res. Met414-Asn426), could be stabilized due to the residue swap. Moreover, the bulky size of the Trp259 side chain requires nearby residues to adjust their positioning to accommodate the introduced residue, weakening the tertiary structure assembly between the C2, PH, and GAP domains. The residue swap potentially causes more severe effects during protein folding or for the SynGAP-membrane interaction than the solvent-only simulations imply.
c.772C>TR258C
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437677-C-T16.20e-7-10.285Likely Pathogenic0.790Likely PathogenicAmbiguous0.771Likely Pathogenic1.17Ambiguous0.41.76Ambiguous1.47Ambiguous0.87Ambiguous-6.79Deleterious1.000Probably Damaging0.993Probably Damaging5.77Benign0.00Affected3.3915-3-47.0-53.05
c.773G>AR258H
(3D Viewer)
C2Benign/Likely benign 36-33437678-G-A106.20e-6-10.533Likely Pathogenic0.525AmbiguousLikely Benign0.830Likely Pathogenic1.60Ambiguous0.61.00Ambiguous1.30Ambiguous1.47Destabilizing-4.06Deleterious1.000Probably Damaging0.991Probably Damaging5.77Benign0.01Affected3.3915201.3-19.05212.581.80.10.0-0.50.2XPotentially PathogenicThe guanidinium group of Arg258, located at the end of an α-β loop connecting the PH domain to the C2 domain (res. Lys251-Arg258), forms hydrogen bonds with the carboxamide groups of Asn727 and Asn729 side chains, as well as with the backbone carbonyl groups of Ala724, Leu725, and Asn727 in the WT simulations. Although the imidazole group of His258 can act as a hydrogen bond donor/acceptor, the swapped residue is unable to maintain an equally well-coordinated hydrogen bond network for linking the C2 and GAP domains in the variant simulations.
c.662A>GE221G
(3D Viewer)
Likely PathogenicPHUncertain 1-12.221Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.863Likely Pathogenic1.40Ambiguous0.11.74Ambiguous1.57Ambiguous0.71Ambiguous-5.56Deleterious0.596Possibly Damaging0.201Benign5.79Benign0.00Affected0-23.1-72.06
c.719A>GD240GLikely PathogenicPHUncertain 1-12.825Likely Pathogenic0.951Likely PathogenicAmbiguous0.912Likely Pathogenic1.85Ambiguous0.12.72Destabilizing2.29Destabilizing0.24Likely Benign-6.19Deleterious0.993Probably Damaging0.984Probably Damaging5.79Benign0.01Affected1-13.1-58.04
c.707C>TA236V
(3D Viewer)
PHBenign/Likely benign 26-33435558-C-T63.72e-6-8.752Likely Pathogenic0.267Likely BenignLikely Benign0.777Likely Pathogenic0.61Ambiguous0.21.08Ambiguous0.85Ambiguous0.64Ambiguous-3.55Deleterious0.981Probably Damaging0.446Benign5.79Benign0.03Affected3.4014002.428.05213.8-44.70.00.0-0.20.2XPotentially BenignThe methyl side chain of Ala236, located on an α helix (residues Ala236-Val250) facing an anti-parallel β sheet strand (residues Ile205-Val209), interacts hydrophobically with nearby residues such as Arg239 and Phe218. In the variant simulations, the isopropyl branched hydrocarbon side chain of Val236 maintains similar hydrophobic interactions as alanine in the WT, with an overall arrangement remarkably similar to Ala236. The residue swap does not affect the protein structure based on the simulations.
c.667A>TT223S
(3D Viewer)
PHConflicting 26-33435518-A-T31.86e-6-7.714In-Between0.410AmbiguousLikely Benign0.535Likely Pathogenic0.26Likely Benign0.10.50Ambiguous0.38Likely Benign0.62Ambiguous-2.86Deleterious0.421Benign0.058Benign5.80Benign0.02Affected3.411311-0.1-14.03200.717.3-0.20.20.00.0XUncertainThe introduced residue Ser223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Its hydroxyl group forms hydrogen bonds with nearby residues Thr228 and Lys207 in the variant simulations, similar to the hydroxyl group of Thr223 in the WT simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and may prevent it from unfolding. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.694G>AA232T
(3D Viewer)
PHBenign 16-33435545-G-A16.20e-7-7.655In-Between0.874Likely PathogenicAmbiguous0.469Likely Benign0.47Likely Benign0.1-0.04Likely Benign0.22Likely Benign0.61Ambiguous-1.42Neutral0.608Possibly Damaging0.240Benign5.80Benign0.09Tolerated3.401410-2.530.03210.8-42.00.50.10.40.5XUncertainThe hydroxyl group of Thr232, located at the end of an anti-parallel β sheet strand (res. Thr228-Ala232), forms hydrogen bonds with nearby residues Glu217, Cys233, and Cys219 in the variant simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and prevent it from unfolding. The new hydrogen bond interactions may be more favorable for structural stability than the steric interactions of the methyl side chain of Ala with the side chains of Gln216 and Cys219 in the WT. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.662A>TE221V
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.954Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.875Likely Pathogenic-0.66Ambiguous0.2-0.89Ambiguous-0.78Ambiguous0.49Likely Benign-5.54Deleterious0.596Possibly Damaging0.203Benign5.86Benign0.00Affected3.4113-2-27.7-29.98234.550.60.00.0-0.40.2XUncertainThe introduced residue Val221 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the carboxylate group of Glu221, Val221 cannot form hydrogen bonds with Thr223 or a salt bridge with the amino group of the Lys207 side chain. Despite this, the WT simulations containing Glu221 do not show significant differences compared to the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.767A>GN256S
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-10.640Likely Pathogenic0.950Likely PathogenicAmbiguous0.707Likely Pathogenic0.31Likely Benign0.20.36Likely Benign0.34Likely Benign0.48Likely Benign-4.33Deleterious0.997Probably Damaging0.970Probably Damaging5.87Benign0.02Affected3.3915112.7-27.03
c.718G>AD240NLikely PathogenicPHUncertain 1-12.942Likely Pathogenic0.755Likely PathogenicLikely Benign0.701Likely Pathogenic0.22Likely Benign0.90.47Likely Benign0.35Likely Benign0.37Likely Benign-4.37Deleterious0.993Probably Damaging0.984Probably Damaging5.88Benign0.01Affected210.0-0.98
c.762G>CK254N
(3D Viewer)
Likely PathogenicPHUncertain 1-13.306Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.757Likely Pathogenic0.73Ambiguous0.21.87Ambiguous1.30Ambiguous1.19Destabilizing-4.23Deleterious0.384Benign0.070Benign5.93Benign0.01Affected3.3915100.4-14.07215.3-21.0-1.01.70.20.3XPotentially PathogenicThe amino group of Lys254, located in an α-β loop connecting the PH and C2 domains (res. Lys251-Arg258), forms salt bridges with the carboxylate groups of Glu244 and Asp684. Since the neutral carboxamide group of the Asn254 side chain cannot form salt bridges with acidic residues, the residue swap potentially weakens the tertiary structure assembly and/or influences the loop positioning. Regardless, in both the variant and WT simulations, all hydrogen bonds formed by the residue’s side chain were broken, and the residue rotated outwards. The partially α helical conformation of the loop, which extends to a nearby α helix (res. Met414-Asn426), is dynamic, making it unclear if the mutation affects it.
c.3361A>GS1121GLikely BenignUncertain 16-33443913-A-G17.00e-7-1.220Likely Benign0.054Likely BenignLikely Benign0.067Likely Benign-0.53Neutral0.003Benign0.004Benign6.63Benign0.00Affected3.775010.4-30.03

Found 757 rows. Show 200 rows per page. Page 4/4 |